These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38759904)

  • 1. Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy.
    Ezad SM; McEntegart M; Dodd M; Didagelos M; Sidik N; Li Kam Wa M; Morgan HP; Pavlidis A; Weerackody R; Walsh SJ; Spratt JC; Strange J; Ludman P; Chiribiri A; Clayton T; Petrie MC; O'Kane P; Perera D;
    J Am Coll Cardiol; 2024 Jul; 84(4):340-350. PubMed ID: 38759904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.
    Perera D; Clayton T; Petrie MC; Greenwood JP; O'Kane PD; Evans R; Sculpher M; Mcdonagh T; Gershlick A; de Belder M; Redwood S; Carr-White G; Marber M;
    JACC Heart Fail; 2018 Jun; 6(6):517-526. PubMed ID: 29852933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial.
    Perera D; Ryan M; Morgan HP; Greenwood JP; Petrie MC; Dodd M; Weerackody R; O'Kane PD; Masci PG; Nazir MS; Papachristidis A; Chahal N; Khattar R; Ezad SM; Kapetanakis S; Dixon LJ; De Silva K; McDiarmid AK; Marber MS; McDonagh T; McCann GP; Clayton TC; Senior R; Chiribiri A;
    JAMA Cardiol; 2023 Dec; 8(12):1154-1161. PubMed ID: 37878295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.
    Liga R; Colli A; Taggart DP; Boden WE; De Caterina R
    J Am Heart Assoc; 2023 Mar; 12(6):e026943. PubMed ID: 36892041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial.
    Chivardi C; Morgan H; Sculpher MJ; Clayton T; Evans R; Dodd M; Petrie M; Rinaldi CA; O'Kane P; Brown L; Perera D; Saramago P;
    Circ Cardiovasc Qual Outcomes; 2024 Jan; 17(1):e010533. PubMed ID: 37929587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction.
    Bista R; Zghouzi M; Jasti M; Lichaa H; Kerrigan J; Haddad E; Alraies MC; Paul TK
    Curr Cardiol Rep; 2024 May; 26(5):435-442. PubMed ID: 38642298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
    Perera D; Clayton T; O'Kane PD; Greenwood JP; Weerackody R; Ryan M; Morgan HP; Dodd M; Evans R; Canter R; Arnold S; Dixon LJ; Edwards RJ; De Silva K; Spratt JC; Conway D; Cotton J; McEntegart M; Chiribiri A; Saramago P; Gershlick A; Shah AM; Clark AL; Petrie MC;
    N Engl J Med; 2022 Oct; 387(15):1351-1360. PubMed ID: 36027563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
    Perera D; Morgan HP; Ryan M; Dodd M; Clayton T; O'Kane PD; Greenwood JP; Walsh SJ; Weerackody R; McDiarmid A; Amin-Youssef G; Strange J; Modi B; Lockie T; Hogrefe K; Ahmed FZ; Behan M; Jenkins N; Abdelaal E; Anderson M; Watkins S; Evans R; Rinaldi CA; Petrie MC;
    Circulation; 2023 Sep; 148(11):862-871. PubMed ID: 37555345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic utility of BCIS myocardial jeopardy score for classification of coronary disease burden and completeness of revascularization.
    De Silva K; Morton G; Sicard P; Chong E; Indermuehle A; Clapp B; Thomas M; Redwood S; Perera D
    Am J Cardiol; 2013 Jan; 111(2):172-7. PubMed ID: 23102883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of coronary revascularization in patients with ischemic left ventricular dysfunction.
    Al-Sadawi M; Tao M; Dhaliwal S; Radakrishnan A; Liu Y; Gier C; Masson R; Rahman T; Tam E; Mann N
    Cardiovasc Revasc Med; 2024 Aug; 65():88-97. PubMed ID: 38503643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete Revascularization.
    Lee JM; Hwang D; Choi KH; Lee HJ; Song YB; Cho YK; Nam CW; Hahn JY; Shin ES; Doh JH; Hoshino M; Hamaya R; Kanaji Y; Murai T; Zhang JJ; Ye F; Li X; Ge Z; Chen SL; Kakuta T; Koo BK
    Circ Cardiovasc Interv; 2020 Sep; 13(9):e009232. PubMed ID: 32895005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention.
    Généreux P; Campos CM; Farooq V; Bourantas CV; Mohr FW; Colombo A; Morel MA; Feldman TE; Holmes DR; Mack MJ; Morice MC; Kappetein AP; Palmerini T; Stone GW; Serruys PW
    Am J Cardiol; 2015 Jul; 116(2):174-86. PubMed ID: 25983123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry.
    Burzotta F; Russo G; Ribichini F; Piccoli A; D'Amario D; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Crea F; Trani C
    J Interv Cardiol; 2019; 2019():5243913. PubMed ID: 31772533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and outcomes of patients with severe left ventricular dysfunction undergoing cardiac MRI viability assessment prior to revascularization.
    Doukas D; Porcaro K; Marot J; Burke L; Joyce C; Weaver F; Nguyen J; Cao JJ; Mathew V; Heroux A; Syed MA
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):675-684. PubMed ID: 33034865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction.
    Abdul Ghaffar Y; Maskoun W; Mustafa NG; Feigenbaum H; Sawada SG
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1651-1659. PubMed ID: 31053980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Russo JJ; Prasad M; Doshi D; Karmpaliotis D; Parikh MA; Ali ZA; Popma JJ; Pershad A; Ohman EM; Douglas PS; O'Neill WW; Leon MB; Moses JW; Kirtane AJ
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):764-770. PubMed ID: 31693292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.
    Romagnoli E; Burzotta F; Cerracchio E; Russo G; Aurigemma C; Pedicino D; Locorotondo G; Graziani F; Leone AM; D'Amario D; Lombardo A; Malara S; Fulco L; Bianchini F; Sanna T; Trani C
    Int J Cardiol; 2023 Sep; 387():131098. PubMed ID: 37290663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.